BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3717177)

  • 21. Impact of a target drug monitoring program on the usage of clindamycin.
    Gin AS; Lipinski LA; Honcharik N
    Can J Hosp Pharm; 1994 Apr; 47(2):53-8. PubMed ID: 10134127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Appropriateness of metronidazole use in a teaching hospital.
    Wang JC; Conly JM; Shafran SD
    Am J Hosp Pharm; 1989 Jul; 46(7):1385-9. PubMed ID: 2757045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a pharmacy-based cost-containment program on cimetidine costs and use.
    Kong KM; Johnson WF; Anderson PO; Sato LA; Simonian RI
    Am J Hosp Pharm; 1987 Sep; 44(9):2068-73. PubMed ID: 3674045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the Hospital Pharmacy Initiative for promoting prudent use of antibiotics in hospitals in England.
    Wickens HJ; Jacklin A
    J Antimicrob Chemother; 2006 Dec; 58(6):1230-7. PubMed ID: 17030518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inventory control: a review for hospital pharmacists.
    Noel MW
    Hosp Pharm; 1978 Nov; 13(11):617, 621-2, 624-5 passim. PubMed ID: 10239348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost analysis of mixing clindamycin and aminoglycosides.
    Abel SR; Olson SM
    Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical committee enforcement of policy limiting postsurgical antibiotic use.
    Nickman NA; Blissenbach HF; Herrick JD
    Am J Hosp Pharm; 1984 Oct; 41(10):2053-6. PubMed ID: 6496494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacist impact on parenteral cephalosporin prescribing.
    Lawlor MC; Lucarotti RL
    Hosp Formul; 1983 Apr; 18(4):402-4, 407-8. PubMed ID: 10259512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metronidazole cost containment: a two-stage intervention.
    Bunz D; Gupta S; Jewesson P
    Hosp Formul; 1990 Nov; 25(11):1167-9, 1177. PubMed ID: 10107821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent antibiotic-use review in a small hospital.
    Kerns MP; Meyer GE
    Am J Hosp Pharm; 1986 Jun; 43(6):1476-8. PubMed ID: 3728483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementing clinical pharmacy services in an outpatient oncology clinic.
    Caselnova DA; Dzierba SH; O'Neill MS; Dillon KR; Farley PC
    Am J Hosp Pharm; 1985 Jun; 42(6):1348-52. PubMed ID: 4014251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a pharmacy resident on hospital length of stay and drug-related costs.
    Terceros Y; Chahine-Chakhtoura C; Malinowski JE; Rickley WF
    Ann Pharmacother; 2007 May; 41(5):742-8. PubMed ID: 17440008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achieving parenteral nutrition cost savings through prescribing guidelines and formulary restrictions.
    Maswoswe JJ; Newcomer DR; Quandt CM
    Am J Hosp Pharm; 1987 Jun; 44(6):1376-81. PubMed ID: 3113237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost containment through restriction of cephalosporins.
    Britton HL; Schwinghammer TL; Romano MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive pharmaceutical services in a small community hospital.
    Chase PA
    Am J Hosp Pharm; 1984 Jul; 41(7):1338-42. PubMed ID: 6465147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the impact of a clinical pharmacist on the quality and cost of pharmacotherapy in a general surgical department, the Hillel-Yaffe Medical Center].
    Schwartzberg E; Livny S; Sterenberg A; Troitsa A; Oren M; Shani S
    Harefuah; 2003 Jan; 142(1):5-9, 80. PubMed ID: 12647481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlling the costs of antibiotic resistance.
    North D
    Clin Ther; 1993; 15 Suppl A():3-11. PubMed ID: 8513459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.